https://doi.org/10.55788/2fd64d51
According to Prof. Eric Loucks (Brown University, RI, USA), mindfulness may support patients to adhere to lifestyle measures that achieve BP control such as physical activity, dietary changes, reduced alcohol consumption, medication adherence and weight loss.
The parallel-group, phase 2, randomised clinical trial MB-BP (NCT03256890) trained participants in skills such as attention control, self-awareness and emotion regulation, and then applied that training to health behaviour changes suitable to improve BP control [1]. The researchers compared enhanced standard care (e.g. a home blood pressure monitor, BP education material, facilitated access to a physician if needed) with the participation in an 8-week mindfulness-based programme, customised for people with elevated BP.
All 200 adult participants were recruited from the Providence, Rhode Island area and had elevated/high BP (>120 mmHg systolic or >80 mmHg diastolic BP). In total, 81% of the participants were White adults and 73% had a college education. Participants were randomised 1:1 to the mindfulness programme or the enhanced standard care group. Participants in the MB-BP group went to a group orientation session, eight 2.5-hour weekly group sessions and one 7.5-hour, one-day group retreat. Recommended home mindfulness practice was at least 45 minutes a day, six days a week.
At 6 months, participants in the mindfulness group displayed a reduction in mean systolic BP of 5.9 mmHg (95% CI -9.1â -2.8; P<0.001), compared with a 1.4 mmHg reduction in systolic BP in the enhanced usual care group in pre-specified unadjusted analyses. In a posthoc analysis that adjusted for the BP and sex strata that participants were randomised within, there was a between-group difference of 4.3 mmHg (95% CI -8.7â0.1) at 6 months follow-up. There were no notable changes in diastolic BP for either group. Participants in the mindfulness group also reduced their sedentary sitting behaviour by an average of 351 minutes each week, were more likely to eat heart-healthy food and reported improved perceived stress and mindfulness levels compared with the participants in the enhanced standard care group, possibly contributing to the BP lowering effect of mindfulness.
Importantly, most participants were college-educated White adults, which limits its generalisability to people from diverse racial and ethnic groups or to those who have other education levels. âI would like to see a replication of this work by external groups with longer follow up, and more generalised participants,â Prof. Loucks concluded.
- Loucks EB, et al. The effect of adapted mindfulness training in participants with elevated office blood pressure: the mindfulness-based blood pressure reduction (MB-BP) randomized clinical trial. LBS.04, AHA Scientific Sessions 2022, 05â07 November, Chicago, USA.
Copyright ©2023 Medicom Medical Publishers
Posted on
Previous Article
« Grafting with the radial vein: an underrated option in CABG surgery? Next Article
Quadruple, ultra-low-dose treatment did not meet primary endpoint in hypertension »
« Grafting with the radial vein: an underrated option in CABG surgery? Next Article
Quadruple, ultra-low-dose treatment did not meet primary endpoint in hypertension »
Table of Contents: AHA 2022
Featured articles
What Is New in Heart Failure
Torsemide not superior to furosemide after hospitalisation for heart failure
IRONMAN failed primary endpoint but shows potential long-term benefits of iron repletion in HF patients
Up-titration of HF therapies following HF discharge saves lives
Hypertension: Novel Developments
The endothelin system: a new target for resistant high blood pressure
Can renal denervation lower BP on top of antihypertensive drugs?
Quadruple, ultra-low-dose treatment did not meet primary endpoint in hypertension
Mindfulness programme contributes to office blood pressure lowering
Interventional Cardiology in 2022
Grafting with the radial vein: an underrated option in CABG surgery?
Extracorporeal membrane oxygenation not superior to conservative therapy in cardiogenic shock
Surgery with adequate saphenous vein partly better than endovascular treatment in CLTI
Arrhythmia â State of the Art
First-line ablation limits progression to persistent AF
Doubling the dose of self-administered etripamil terminates PSVT
Novel Developments in Primary and Secondary Prevention
Grafting with the radial vein: an underrated option in CABG surgery?
Digitally delivered cognitive behavioural therapy successful in type 2 diabetes
Empagliflozin reduces risk of kidney disease progression and CV events in patients with CKD
RESPECT-EPA misses primary endpoint but hints towards improvements in CV outcomes by EPA
Pemafibrate fails to reduce cardiovascular events in diabetes but may benefit the liver
Dietary supplements not effective in lowering LDL-C, use of low-dose statins encouraged
No sex differences in lipid-lowering effect and treatment benefit of PCSK9 inhibitors
COVID-19 and the Heart
‘Noâ to routine use of rivaroxaban in outpatients with COVID-19
COVID-19 pandemic: Older adults and those affected by the delta variant experienced increased cardiovascular morbidity and mortality
COVID-19 mRNA vaccination does not amplify risk of cardiovascular hospitalisation
Best of the Posters
Higher LDL-cholesterol levels linked to higher CVD mortality risk in the elderly
AF: Moderate alcohol intake possibly associated with a reduced mortality risk
Periodontitis: An independent risk factor for AF
Related Articles
January 11, 2023
Mindfulness programme contributes to office blood pressure lowering
January 11, 2023
First-line ablation limits progression to persistent AF
January 11, 2023
Olpasiran leads to dramatic reductions in Lp(a) concentrations
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com